Metabolic abnormalities associated with tobramycin therapy.
D000328:Adult; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D007008:Hypokalemia / Q000139:chemically induced*; D008274:Magnesium / Q000652:urine; D008275:Magnesium Deficiency / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009399:Nephrons / Q000503:physiopathology; D014031:Tobramycin / Q000009:adverse effects*
D008274:Magnesium; D014031:Tobramycin